Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.

S. Zanardi, R. De Menech, G. Pino, D. Guarneri, G. Dandolo, M. Sanguineti, M. G. Moro, G. P. Barbi, M. Paganuzzi, F. Boccardo

Research output: Contribution to journalArticle

Abstract

The potential synergism of sequential combinations of tamoxifen (TMX) or estradiol benzoate (E2B) with medroxyprogesterone acetate (MPA) in inhibiting the growth of 7.12-dimethylbenz(a)anthracene(DMBA) - induced rat mammary tumors has been investigated. In addition, the effect of TMX and E2B on estrogen and progesterone receptors' (ERs and PgRs) synthesis has been evaluated in the attempt to elucidate possible mechanisms involved. Previous treatment both with TMX and E2B has been shown to strongly enhance the antitumor activity of MPA. A priming on PgR synthesis has been observed only after E2B administration, TMX producing a sharp decrease in PgR levels. It is concluded that, while the priming action exerted by E2B on PgRs might explain the potentiating effect shown by E2B on MPA activity, the synergism observed between TMX and MPA should be explained on an extrareceptorial basis, an induction on PgR synthesis by TMX not being evident at the dosage and priming time employed in this study.

Original languageEnglish
Pages (from-to)239-242
Number of pages4
JournalChemioterapia
Volume4
Issue number3
Publication statusPublished - Jun 1985

Fingerprint

9,10-Dimethyl-1,2-benzanthracene
Medroxyprogesterone Acetate
Tamoxifen
Breast Neoplasms
Growth
Progesterone Receptors
Estrogen Receptors
estradiol 3-benzoate

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)

Cite this

Zanardi, S., De Menech, R., Pino, G., Guarneri, D., Dandolo, G., Sanguineti, M., ... Boccardo, F. (1985). Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma. Chemioterapia, 4(3), 239-242.

Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma. / Zanardi, S.; De Menech, R.; Pino, G.; Guarneri, D.; Dandolo, G.; Sanguineti, M.; Moro, M. G.; Barbi, G. P.; Paganuzzi, M.; Boccardo, F.

In: Chemioterapia, Vol. 4, No. 3, 06.1985, p. 239-242.

Research output: Contribution to journalArticle

Zanardi, S, De Menech, R, Pino, G, Guarneri, D, Dandolo, G, Sanguineti, M, Moro, MG, Barbi, GP, Paganuzzi, M & Boccardo, F 1985, 'Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.', Chemioterapia, vol. 4, no. 3, pp. 239-242.
Zanardi S, De Menech R, Pino G, Guarneri D, Dandolo G, Sanguineti M et al. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma. Chemioterapia. 1985 Jun;4(3):239-242.
Zanardi, S. ; De Menech, R. ; Pino, G. ; Guarneri, D. ; Dandolo, G. ; Sanguineti, M. ; Moro, M. G. ; Barbi, G. P. ; Paganuzzi, M. ; Boccardo, F. / Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma. In: Chemioterapia. 1985 ; Vol. 4, No. 3. pp. 239-242.
@article{820a2c6de96d4d9ca07167037f1b5933,
title = "Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.",
abstract = "The potential synergism of sequential combinations of tamoxifen (TMX) or estradiol benzoate (E2B) with medroxyprogesterone acetate (MPA) in inhibiting the growth of 7.12-dimethylbenz(a)anthracene(DMBA) - induced rat mammary tumors has been investigated. In addition, the effect of TMX and E2B on estrogen and progesterone receptors' (ERs and PgRs) synthesis has been evaluated in the attempt to elucidate possible mechanisms involved. Previous treatment both with TMX and E2B has been shown to strongly enhance the antitumor activity of MPA. A priming on PgR synthesis has been observed only after E2B administration, TMX producing a sharp decrease in PgR levels. It is concluded that, while the priming action exerted by E2B on PgRs might explain the potentiating effect shown by E2B on MPA activity, the synergism observed between TMX and MPA should be explained on an extrareceptorial basis, an induction on PgR synthesis by TMX not being evident at the dosage and priming time employed in this study.",
author = "S. Zanardi and {De Menech}, R. and G. Pino and D. Guarneri and G. Dandolo and M. Sanguineti and Moro, {M. G.} and Barbi, {G. P.} and M. Paganuzzi and F. Boccardo",
year = "1985",
month = "6",
language = "English",
volume = "4",
pages = "239--242",
journal = "Chemioterapia",
issn = "0392-906X",
publisher = "Editrice Giuntina",
number = "3",

}

TY - JOUR

T1 - Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.

AU - Zanardi, S.

AU - De Menech, R.

AU - Pino, G.

AU - Guarneri, D.

AU - Dandolo, G.

AU - Sanguineti, M.

AU - Moro, M. G.

AU - Barbi, G. P.

AU - Paganuzzi, M.

AU - Boccardo, F.

PY - 1985/6

Y1 - 1985/6

N2 - The potential synergism of sequential combinations of tamoxifen (TMX) or estradiol benzoate (E2B) with medroxyprogesterone acetate (MPA) in inhibiting the growth of 7.12-dimethylbenz(a)anthracene(DMBA) - induced rat mammary tumors has been investigated. In addition, the effect of TMX and E2B on estrogen and progesterone receptors' (ERs and PgRs) synthesis has been evaluated in the attempt to elucidate possible mechanisms involved. Previous treatment both with TMX and E2B has been shown to strongly enhance the antitumor activity of MPA. A priming on PgR synthesis has been observed only after E2B administration, TMX producing a sharp decrease in PgR levels. It is concluded that, while the priming action exerted by E2B on PgRs might explain the potentiating effect shown by E2B on MPA activity, the synergism observed between TMX and MPA should be explained on an extrareceptorial basis, an induction on PgR synthesis by TMX not being evident at the dosage and priming time employed in this study.

AB - The potential synergism of sequential combinations of tamoxifen (TMX) or estradiol benzoate (E2B) with medroxyprogesterone acetate (MPA) in inhibiting the growth of 7.12-dimethylbenz(a)anthracene(DMBA) - induced rat mammary tumors has been investigated. In addition, the effect of TMX and E2B on estrogen and progesterone receptors' (ERs and PgRs) synthesis has been evaluated in the attempt to elucidate possible mechanisms involved. Previous treatment both with TMX and E2B has been shown to strongly enhance the antitumor activity of MPA. A priming on PgR synthesis has been observed only after E2B administration, TMX producing a sharp decrease in PgR levels. It is concluded that, while the priming action exerted by E2B on PgRs might explain the potentiating effect shown by E2B on MPA activity, the synergism observed between TMX and MPA should be explained on an extrareceptorial basis, an induction on PgR synthesis by TMX not being evident at the dosage and priming time employed in this study.

UR - http://www.scopus.com/inward/record.url?scp=0022084683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022084683&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 239

EP - 242

JO - Chemioterapia

JF - Chemioterapia

SN - 0392-906X

IS - 3

ER -